Adaptive Biotechnologies CEO Flags MRD Momentum, Lifts 2025 Volume Outlook to 30%+ at TD Cowen Conf. [Yahoo! Finance]
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: Yahoo! Finance
2025 volume guidance from "25%+" to , and the company expects to meet or beat that target as community adoption increases. Key operational tailwinds include EMR integration (repeat-order compliance ~63–65%), guideline inclusions, and expected payer wins that management says should lift realized price from $1,307 to about and broaden coverage by indication. Management now targets substantial margin improvement at scale — forecasting 75–80% gross margins and 20–25% operating margins — while pursuing capital-efficient international expansion and selective partnerships (e.g., Genentech) as upside. Interested in Adaptive Biotechnologies Corporation? Here are five stocks we like better. Adaptive Biotechnologies (NASDAQ:ADPT) CEO Chad Robins told investors at the 46th Annual TD Cowen Healthcare Conference that the company is looking to build on what he described as strong recent performance in minimal residual disease (MRD) testing, while continuing to invest in its immune medicine e
Show less
Read more
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Why are Analysts Optimistic About Adaptive Biotechnologies (ADPT)? [Yahoo! Finance]Yahoo! Finance
- TD Cowen is Bullish on Adaptive Biotechnologies Corporation (ADPT) [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies (NASDAQ:ADPT) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ADPT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall MarketBeat
- Adaptive Biotechnologies (NASDAQ:ADPT) had its price target raised by analysts at JPMorgan Chase & Co. from $20.00 to $21.00. They now have an "overweight" rating on the stock.MarketBeat
ADPT
Earnings
- 2/5/26 - Beat
ADPT
Sec Filings
- 3/4/26 - Form 4
- 3/3/26 - Form 4
- 3/3/26 - Form 144
- ADPT's page on the SEC website